Stockscreener 앱 받기
14.89
3.28%
-0.485
시간 외 거래:
14.86
-0.035
-0.23%
Dr Reddys Laboratories Ltd Adr 주식(RDY)의 최신 뉴스
Dr. Reddy’s Laboratories files FY26 annual report with US SEC - scanx.trade
RDDA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Dr. Reddy's Laboratories Ltd. Sponsored ADR – MUN:RDDA - TradingView
Dr. Reddy's Labs ADR files Form 20-F, shares stay tied to US pharma peers - AD HOC NEWS
Dr. Reddy’s files 2026 annual report with the SEC - Stock Titan
659157 Forecast — Price Target — Prediction for 2027 - TradingView
Form 6K DR REDDYS LABORATORIES LTD For: 22 June By Investing.com - Investing.com Nigeria
Form 6K Kinross Gold Corp For: 22 June By Investing.com - Investing.com Nigeria
Dr. Reddy’s (NYSE: RDY) allots 6,730 ESOP shares to employees - Stock Titan
Why Dr. Reddy's Venlafaxine XR capsules quietly matter for everyday patients - AD HOC NEWS
Why Dr. Reddy’s Celevida Maxx matters for Indian diabetics - AD HOC NEWS
RDY News | DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) - ChartMill
Dr. Reddy's Labs (ADR) Stock (US2565981035): Earnings and valuation keep the ADR in focus - Ad-hoc-news.de
Dr. Reddy's Laboratories Ltd Stock (INE089A01023): U.S. Bosutinib Launch And Pre-market Drop Put ADR - Ad-hoc-news.de
Dr. Reddy's Laboratories stock (INE089A01023): focus on recent FDA progress and US generics growth - AD HOC NEWS
[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
With Lenalidomide Headwinds Behind, Dr. Reddy's Turns to Biosimilars and Consumer Health for Growth - Morningstar
Dr. Reddy’s (NYSE: RDY) allots 12,100 ESOP shares, updates capital - Stock Titan
Dr. Reddy’s Laboratories issues 12,100 equity shares under stock options scheme - Business Upturn
Topicus submits revised $2.00 per share proposal for ReadyTech - Investing.com UK
Topicus submits revised $2.00 per share proposal for ReadyTech By Investing.com - Investing.com India
Dr. Reddy's Laboratories Ltd ADR (RDY-N) Stock Price and News - The Globe and Mail
Generic Ozempic to hit pharmacies this week, but availability will vary across Canada - The Globe and Mail
Earnings call transcript: Dr. Reddy’s Q4 2026 misses earnings expectations - Investing.com UK
Earnings call transcript: Dr. Reddy’s Q4 2026 misses earnings expectations By Investing.com - Investing.com India
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Sahm
Dr. Reddy's Laboratories Ltd stock (INE089A01023): earnings miss and dual-market focus draw attentio - AD HOC NEWS
Dr. Reddy's Laboratories stock: Earnings miss shapes outlook - Ad-hoc-news.de
8 Stocks To Buy For Long Term: Analysts recommend 3 largecap, 3 midcap, 2 smallcap scrips; Dr Reddy's Labs on the list - Zee Business
Dr. Reddy’s Labs ADR earnings missed by $0.05, revenue fell short of estimates - Investing.com India
Kotak maintains Reduce rating on Dr. Reddy’s stock on margin miss By Investing.com - Investing.com Nigeria
Dr. Reddy's Earnings: Lenalidomide's Slide Digs Into Numbers, but Base Business Remains Solid - Morningstar
Earnings call transcript: Dr. Reddy’s Q4 2026 revenue misses forecast - Investing.com
Earnings call transcript: Dr. Reddy’s Q4 2026 revenue misses forecast By Investing.com - Investing.com Australia
Dr. Reddy's Laboratories Ltd stock (INE089A01023): Board meeting set for Q4 FY26 results - AD HOC NEWS
Dr. Reddy’s (NYSE: RDY) approves new ESOP and ADR stock option grants - Stock Titan
Dr. Reddy's Grants Employee Stock Options, Raising Dilution Concerns - Whalesbook
Dr. Reddy’s Laboratories grants over 1.19 million stock options to employees - Business Upturn
Dr. Reddy’s Laboratories Board Approves New Stock Option Grants for Employees - InvestyWise
RDY Stock Price, Quote & Chart | DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) - ChartMill
Dr. Reddy's Laboratories Ltd. Sponsored ADR Trade Ideas — LS:659157 - TradingView
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada - ChartMill
Earnings BeforeStock ScreenerSnapshot - Finviz
Dr. Reddy's on Pace for Largest Percent Increase Since June 2025 — Data Talk - Morningstar
Dr. Reddy's Labs (ADR) stock (US2565981035): Why Google Discover changes matter more now - AD HOC NEWS
GDR, ADR & IDR Companies Stock Prices | IIFL Capital - India Infoline
5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - MSN
Dr Reddy’s (NYSE: RDY) Europe head reports 8,450 ADR-backed shares - Stock Titan
Dr. Reddy’s (NYSE: RDY) North America CEO reports 47,325 ADR shares - Stock Titan
ExxonMobil Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Dr. Reddy's Laboratories Allots 3,675 Equity Shares Under Employee Stock Option Plan - scanx.trade
Employee stock options add 3,675 Dr. Reddy’s (NYSE: RDY) shares - Stock Titan
0.61%
4.75%
자본화:
|
볼륨(24시간):